SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Larter Joseph

(Last) (First) (Middle)
1617 W. 6TH STREET
SUITE C

(Street)
AUSTIN TX 78703

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SECURECARE TECHNOLOGIES INC [ SCUC.OB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
01/19/2010
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock Par Value $.001 939,276 D
Common Stock Per Value $.001 01/19/2010 P 6,100 A $0(6) 1,254,173 I See Footnote(1)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Series A Warrants $200 06/02/2004 06/01/2009 Common Stock Par Value $.001 500 500 I See Footnote(2)
Series A Warrants $200 05/13/2004 05/12/2009 Common Stock Par Value $.001 500 500 I See Footnote(2)
Series B Warrants $250 12/09/2004 12/08/2009 Common Stock Par Value $.001 23 23 D
Series B Warrants $250 03/11/2005 03/10/2010 Common Stock Par Value $.001 182 182 I See Footnote(3)
Series B Warrants $250 12/21/2004 12/20/2009 Common Stock Par Value $.001 23 23 I See Footnote(3)
Series B Warrants $250 03/11/2005 03/10/2010 Common Stock Par Value $.001 182 182 I See Footnote(3)
Stock Purchase Warrants $0.4(7) 02/13/2007 02/12/2012 Common Stock Par Value $.001 33,400 33,400 I See Footnote(4)
Stock Purchase Warrants $0.4(7) 12/19/2006 12/20/2011 Common Stock Par Value $.001 5,000 5,000 I See Footnote(4)
Stock Purchase Warrants $0.4(7) 01/19/2007 01/18/2012 Common Stock Par Value $.001 5,000 5,000 I See Footnote(4)
Stock Purchase Warrants $0.4(7) 05/09/2007 05/08/2012 Common Stock Par Value $.001 6,000 6,000 I See Footnote(4)
Stock Option(5) $0.75 07/29/2008 A 200,000 07/29/2008 07/29/2018 Common Stock Par Value $.001 200,000 $0 200,000 D
Explanation of Responses:
1. 448,676 of these common stock shares are owned by The Joseph Trust, the undersigned is a Trustee of such Trust; 427,232 of these common stock shares are owned by Marldene Limited, the undersigned is a director of Marldene Limited; 177,035 of these common stock shares are owned by SLT Ltd. and Joseph and Betty Larter being the current trustees of the Marldene Directors Pension Scheme, the undersigned is a Trustee of SLT Ltd. and Joseph and Betty Larter being the current trustees of the Marldene Director's Pension Scheme; 201,230 of these common stock shares are owned by Marldene Limited Directors Pension Scheme, the undersigned is a Trustee of the Marldene Limited Directors Pension Scheme.
2. 100,000 of the Series A Warrants, which convert to 500 shares of common stock are owned by The Joseph Trust, the undersigned is an Trustee of such Trust; 100,000 of the Series A Warrants, which convert to 500 shares of common stock are owned by SLT Ltd. and Joseph and Betty Larter being the current trustees of the Marldene Directors Pension Scheme, the undersigned is a Trustee of SLT Ltd. and Joseph and Betty Larter being the current trustees of the Marldene Director's Pension Scheme.
3. 36,364 of the Series B Warrants, which convert to 182 shares of common stock are owned by Marldene Limited, the undersigned is a director of Marldene Limited; 40,909 of the Series B warrants, which convert to 205 shares of common stock are owned by SLT Ltd. and Joseph and Betty Larter being the current trustees of the Marldene Directors Pension Scheme, the undersigned is a Trustee of SLT Ltd. and Joseph and Betty Larter being the current trustees of the Marldene Director's Pension Scheme.
4. 33,400 of the Stock Purchase Warrants, which convert to 33,400 shares of common stock are owned by The Joseph Trust, the undersigned is a Trustee of such Trust. 16,000 of the Stock Purchase Warrants, which convert to 16,000 shares of common stock are owned by SLT Ltd. and Joseph and Betty Larter being the current trustees of the Marldene Directors Pension Scheme, the undersigned is a Trustee of SLT Ltd. and Joseph and Betty Larter being the current trustees of the Marldene Director's Pension Scheme.
5. The stock options vest 100% immediately on July 29, 2008.
6. The reporting person, a trustee of the Marldene Limited Directors Pension Scheme, consented to the terms and conditions of the Company's note extension offer and in conjunction with the reporting person's consent $2,440 in accrued interest on certain notes payable was converted to 6,100 shares of common stock. The Company issued one share of common stock for each $0.40 in accrued interest converted.
7. The exercise price of the stock purchase warrants was reduced to $.40 from $2.50 in exchange for the reporting person agreeing to the terms and conditions of the Company's note extension offer.
Remarks:
/s/ JOSEPH LARTER 02/10/2010
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.